Next-generation Immune Repertoire Sequencing Market: Rise in need of better anti-cancer treatment to drive the market
Next-generation Immune Repertoire Sequencing Market: Introduction
- Profiling of T- and B-cell receptor repertoires in an individual has led to a vast repository of information on acquired immunity against various microorganisms. Next-generation immune repertoire sequencing has allowed researchers to make sophisticated immuno-bioinformatics analyses. It has generated interest among the research community and biopharmaceutical industries in the clinical development of antibody engineering, vaccine design, and cellular immunotherapy. Rise in applications of nutritional and intestinal immunology drives the rapid evolution of next-generation immune repertoire sequencing. The innovative technology has provided unprecedented insights into host-microbiome immune homeostasis, and along with single-cell transcriptomics presents significant opportunities in the life sciences industries across the world.
Read Report Overview -
https://www.transparencymarketresearch.com/next-generation-immune-repertoire-sequencing-market.html
- Immune repertoire sequencing is utilized in biomarker discovery to enhance the success rate and cost-effectiveness of rational drug development. For instance, in November 2017, the Center for Commercialization of Cancer Immunotherapy (C3i) started offering T cell receptor-beta sequencing services in its Biomarker and Diagnostic unit in Canada. Rise in demand for personalized medicine is anticipated to support the immune repertoire sequencing market growth, as personalized medicine uses an individual’s genetic profile to guide decisions made with regard to the prevention, diagnosis, and treatment of diseases.
Key Drivers, Restraints, and Opportunities of Global Next-generation Immune Repertoire Sequencing Market
- Rise in need of expanding the understanding of key processes in systems immunology is a key factor driving the demand for next-generation immune repertoire sequencing. Increase in applications of TCR repertoire sequencing in clinical settings is one of the key aspects in improving immune repertoire sequencing. Over the past several years, this has generated a groundswell of interest in this high-throughput sequencing in realms of nutritional and intestinal immunology. Its potential application in gaining insight into lymphocyte diversity has gained some traction, catalyzing the market’s growth. For example, next-generation immune repertoire sequencing has potential in detecting minimal residual disease in lymphoid malignancies post treatment. This helps in evaluating the effectiveness of vaccination.
Request Brochure of Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=58701
- Furthermore, increase in the role of next-generation immune repertoire sequencing for personalized immune modulation is a key trend in the global next-generation immune repertoire sequencing market. Rise in need of better anti-cancer treatment will galvanize research into immune therapy and vaccine development with the help of next-generation immune repertoire sequencing. New avenues in intestinal immunology will pave the way for new, exciting products in the market.
North America to Capture Major Share of Global Next-Generation Immune Repertoire Sequencing Market
Developed regions such as North America and Europe are expected to make significant progress and likely to account for substantial share of the global next-generation immune repertoire sequencing market in terms of revenue. The market in North America is driven by growing traction that immunotherapy has gained in the treatment of cancer and infectious diseases. Developments in Europe are expected to be driven by sizeable funding in biomedical research and rise in research in genomic and autoimmune disease.
Request for Analysis of COVID-19 Impact on Next-generation Immune Repertoire Sequencing Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=58701
North America is anticipated to dominate the global market during the forecast period due to the presence of key industry players in the region (including Thermo Fisher Scientific, Illumina Inc., Pacific Biosciences, and CD Genomics). These players are increasingly focusing on development of novel technologies for immune repertoire sequencing. For example, in 2017, 10x Genomics Inc., a U.S.-based company, added B-Cell and 5’Unbiased Enrichment Kit to its chromium immune repertoire profiling solution or immune repertoire sequencing.
The market in Europe is likely to grow at a rapid pace in the next few years. The market in the region is anticipated to gain momentum during the forecast period, due to increase in funding by the government bodies to assist international innovative projects and marketable innovative products, processes, and services, in order to cater to unmet medical needs. In July 2018, Eurostars (a joint program between EUREKA and the European Commission) granted US$ 495,000 to OSE Immunotherapeutic SA’s project titled: ‘Treatment Response Monitoring for Cancer Immunotherapies utilizing Immune Repertoire Analysis’.
Pre Book Next-generation Immune Repertoire Sequencing Market Report at –
https://www.transparencymarketresearch.com/checkout.php?rep_id=58701<ype=S
Key Players Operating in Global Next-generation Immune Repertoire Sequencing Market
The presence of several prominent players in developed regions has raised the intensity of competition in the global market in the past few years. These players make significant investments in research & development of immuno-bioinformatics analyses using next-generation immune repertoire sequencing.
Major players operating in the global next-generation immune repertoire sequencing market are:
- Adaptive Biotechnologies
- Atreca, Inc.
- CD Genomics
- Pacific Biosciences
- Juno Therapeutics
- Roche Holding AG
- ArcherDX, Inc.
- Illumina, Inc.
- Abvitro (Now Juno Therapeutics)
- Agilent Technologies
- Bgi
- Irepertoire, Inc.
- Oxford Nanopore Technologies, Ltd.
- Qiagen N.V.
- Takara Bio, Inc.
- Thermo Fisher Scientific
- Others
More Trending Reports by Transparency Market Research:
Veterinary Diagnostics Market: The vet laboratory provides a safe place to perform medical testing of infectious agents or toxins in animal diagnostic samples. Veterinary professionals representing public officials related to scientists, animal owners, public health, or wildlife management submit the animal samples for analysis.
Biomarkers Market: A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help in diagnosing the health of patients. The U.S. Food and Drug Administration (FDA) has approved the usage of biomarkers as surrogate end-points in the treatment development process.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/